Research analysts at StockNews.com assumed coverage on shares of IRIDEX (NASDAQ:IRIX – Get Rating) in a report issued on Tuesday. The brokerage set a “buy” rating on the medical equipment provider’s stock.
IRIDEX Stock Performance
Shares of IRIDEX stock opened at $2.25 on Tuesday. The firm has a market cap of $36.02 million, a PE ratio of -5.00 and a beta of 1.25. The firm’s 50-day simple moving average is $2.18 and its 200-day simple moving average is $2.19. IRIDEX has a 1 year low of $1.96 and a 1 year high of $3.49.
IRIDEX (NASDAQ:IRIX – Get Rating) last issued its earnings results on Thursday, March 9th. The medical equipment provider reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.04. The business had revenue of $15.20 million for the quarter, compared to analyst estimates of $15.17 million. IRIDEX had a negative net margin of 13.25% and a negative return on equity of 39.69%. On average, equities analysts predict that IRIDEX will post -0.45 earnings per share for the current year.
Institutional Investors Weigh In On IRIDEX
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A.
- Get a free copy of the StockNews.com research report on IRIDEX (IRIX)
- FREYR Battery Is An Interesting Play On EVs: At Rock Bottom
- Analysts Upgrade GXO Logistics, Its First Quarter Says It All
- The Bottom Is In For AppLovin; Reversal Is Next
- Exact Sciences Serves Investors Exactly What They Wished For
- Shockwave Medical, Fast Grower, In Boston Scientific’s Sights?
Receive News & Ratings for IRIDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX and related companies with MarketBeat.com's FREE daily email newsletter.